A study to assess efficacy and safety of efgartigimod in adults with Sjogren’s disease-associated sensorimotor polyneuropathy or sensory polyneuropathy (SERENITY)

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: 3260d9010a8993562770c4c6ab16292a2c3c0bec
First added on: Oct 31, 2026